PanoramicaGraficoNotizieSchermataTrader

Esperite NV/  NL0009272137  /

Euronext - Amsterdam
28/10/2022  17:35:02 Var. - Volume Denaro03:00:48 Lettera03:00:48 Max Min
0.0092EUR - 1.97 mill.
Fatturato: 18,928.8390		 -Quantità in denaro: - -Quantità in lettera: - 0.0102 0.0090
GlobeNewswire 10/10/2019 Worldwide DNA Read, Write & Edit Markets to 2024 | Technologies, Applications, Innovations, Patents,...
GlobeNewswire 19/07/2019 Whole Genome and Exome Sequencing Markets, 2019-2023 by Research, Clinical, Direct to Consumer, Agri...
GlobeNewswire 28/05/2019 DNA Sequencing Research, Applied and Clinical Markets, 2023
GlobeNewswire 10/01/2019 ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 24th tranche of investm...
GlobeNewswire 30/11/2018 ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 23rd tranche of investm...
GlobeNewswire 29/11/2018 Esperite (ESP) with The Cell Factory, prepares to raise series A round of investments to continue it...
GlobeNewswire 27/11/2018 ESPERITE N.V. convenes Annual General Meeting of Shareholders
GlobeNewswire 23/11/2018 ESPERITE (ESP): financial results for 2017 are published.
GlobeNewswire 19/11/2018 ESPERITE (ESP) announces publication of its Annual Report 2017 before 24 November 2018
GlobeNewswire 09/11/2018 ESPERITE (ESP) expects publication of Annual Report 2017 before 17 November 2018
GlobeNewswire 08/11/2018 Whole Genome and Exome Sequencing: Worldwide Market Opportunities (2018-2022) Featuring 40+ Key Play...
GlobeNewswire 07/11/2018 Esperite Group with The Cell Factory, expands its patent portfolio on extra-cellular vesicles biolog...
GlobeNewswire 06/11/2018 Esperite Group with The Cell Factory expands its Extracellular Vesicles product portfolio of anti-in...
GlobeNewswire 15/10/2018 ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 22nd tranche of investm...
GlobeNewswire 03/10/2018 Esperite N.V. (ESP): Sale by Esperite of stake in Cryo-Save South Africa cancelled
GlobeNewswire 13/09/2018 ESPERITE N.V. (ESP) WITH CRYOSAVE READY TO STORE MORE THAN A MILLION SAMPLES IN ITS NEW DESIGNED CR...
GlobeNewswire 31/08/2018 Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2017.
GlobeNewswire 29/08/2018 ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 21st tranche of investm...
GlobeNewswire 15/08/2018 Esperite N.V. (ESP) : Update on the publication of the Annual Report 2017.
GlobeNewswire 18/07/2018 Esperite N.V. (ESP) : Additional delays needed on the publication of the Annual Report 2017
GlobeNewswire 09/07/2018 Global Strategic Business Outlook on the Genetic Testing Market 2016-2018 to 2024: Ballooning Global...
GlobeNewswire 02/07/2018 ESPERITE N.V. (ESP) SELLS ITS STAKE IN CRYOSAVE SOUTH AFRICA TO GO LIFE HEALTHCARE (GLI).
GlobeNewswire 28/06/2018 ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 20th tranche of investm...
GlobeNewswire 26/06/2018 Global Whole Genome and Exome Sequencing Markets 2018-2022 & 2023: Diagnostic Factors, Interpreting ...
GlobeNewswire 19/06/2018 Esperite N.V. secures external financing of up to EUR 5 million to support its commercial activity a...